Outset Medical, Inc. (OM) Stock

Outset Medical, Inc. is a pioneering medical technology company based in San Jose, California, specializing in the development of innovative hemodialysis systems. The company's flagship product, the Tablo Hemodialysis System, redefines dialysis care with its compact console that integrates water purification, on-demand dialysate production, and advanced software and connectivity capabilities.

Originally known as Home Dialysis Plus, Ltd., Outset Medical underwent a name change to Outset Medical, Inc. in January 2015, reflecting its evolution and expanded focus within the healthcare technology sector. Since its inception in 2003, the company has remained at the forefront of advancing hemodialysis technology, aiming to enhance patient outcomes and streamline dialysis procedures.

The Tablo Hemodialysis System is designed to provide flexible treatment options for both acute care settings and home dialysis environments. It empowers healthcare providers with simplified workflows and real-time data insights, ensuring efficient and personalized care delivery for patients undergoing dialysis treatment.

Committed to innovation and patient-centric solutions, Outset Medical continues to drive forward with its mission to transform dialysis care through technological advancements. With a strategic focus on improving the dialysis experience and expanding accessibility to high-quality healthcare, the company stands poised to shape the future of renal therapy worldwide.